Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or planned new fundraising through debt or equity in the Q2 FY '26 conference call. The company recently completed an IPO (listing on NSE and BSE on August 26), which was used to strengthen the balance sheet and partly repay borrowings. Significant repayment of Rs. 140 crores debt was made, improving the net debt to equity ratio from 0.8x to 0.3x, indicating a focus on deleveraging rather than new borrowing. The management has not announced any new capital raising plans during this call. Focus appears to be on utilizing existing resources for

Any current/future capex/capital investment/strategic investment?

GEM Aromatics is investing in a multi-purpose plant, with Phase-II (primarily for Phenol derivatives such as MEHQ and Guaiacol) becoming operational by November 30, 2025, with production starting around January/February 2026. The company is adding a capacity of around 10,829 MTPA focusing largely on Phenol derivatives. The Cooling Agent production is set to commence by November 30, 2025, with reasonable utilization expected from December 2025 and normalization in FY '27. The company is fast-tracking the launch of value-added specialty aroma chemical products, originally planned for FY '27 and

Future growth expectations in sales/revenue/volumes?

GEM Aromatics anticipates revenue growth from new customers, especially in the Cooling Agents segment, starting from Q4 FY '26 and continuing into FY '27. The company aims to reduce dependence on the Mint portfolio (which was 70% of revenue in FY '25) by fast-tracking value-added specialty products and aroma chemicals targeted at domestic and export markets. Production of Cooling Agents is set to commence by November 30, 2025, with reasonable utilization expected from December onwards, leading to topline growth in that category in FY '27. The newly set up multipurpose plant (Phase-II) fo

Future growth expectations in earnings/operating earnings/profits/EPS?

GEM Aromatics aims for EBITDA of Rs. 1,050-Rs. 1,100 crores by FY '28 with margins of 16%-18%. The company plans to reduce dependence on Mint and Mint derivatives by ramping up value-added specialty aroma chemical products starting FY '27. Production of Cooling Agents to commence by November 30, 2025, with topline contribution expected from Q4 FY '26 and normalized capacity utilization in FY '27. Fast-tracking new product launches (e.g., Phenol derivatives like BHA) to replace Mint segment revenues and improve margins. Management expects stabilization of the current demand blip by Q4 F

Gem Aromatics LtdQ2 FY26Chemicals & Petrochemicals

Gem Aromatics Ltd Q2 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹139.53Market Cap: ₹727 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

GEM Aromatics anticipates revenue growth from new customers, especially in the Cooling Agents segment, starting from Q4 FY '26 and continuing into FY '27.
The company aims to reduce dependence on the Mint portfolio (which was 70% of revenue in FY '25) by fast-tracking value-added specialty products and aroma chemicals targeted at domestic and export markets.
Production of Cooling Agents is set to commence by November 30, 2025, with reasonable utilization expected from December onwards, leading to topline growth in that category in FY '27.
The newly set up multipurpose plant (Phase-II) for Phenol derivatives will become operational by early FY '27, contributing to capacity and product diversity.
GEM Aromatics expects a normalized demand recovery and stabilization by Q4 FY '26 as external tariff and GST-related issues subside.
The company targets operating EBITDA margins of 16%-18% by FY '28 with scaled revenues from new product lines and operational efficiency improvements.

Margin guidance

Category 3

GEM Aromatics aims for EBITDA of Rs. 1,050-Rs. 1,100 crores by FY '28 with margins of 16%-18%.
The company plans to reduce dependence on Mint and Mint derivatives by ramping up value-added specialty aroma chemical products starting FY '27.
Production of Cooling Agents to commence by November 30, 2025, with topline contribution expected from Q4 FY '26 and normalized capacity utilization in FY '27.
Fast-tracking new product launches (e.g., Phenol derivatives like BHA) to replace Mint segment revenues and improve margins.
Management expects stabilization of the current demand blip by Q4 FY '26, leading to normalization and growth.
Focus on technology-driven innovation, import substitution, and sustainability to drive long-term profitable growth.
Gross margins expected to recover to long-term averages once external pressures (GST, tariffs) subside.

See what Gem Aromatics Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no explicit mention of any current or planned new fundraising through debt or equity in the Q2 FY '26 conference call.
The company recently completed an IPO (listing on NSE and BSE on August 26), which was used to strengthen the balance sheet and partly repay borrowings.
Significant repayment of Rs. 140 crores debt was made, improving the net debt to equity ratio from 0.8x to 0.3x, indicating a focus on deleveraging rather than new borrowing.
The management has not announced any new capital raising plans during this call.
Focus appears to be on utilizing existing resources for ongoing CAPEX and growth initiatives, with no indication of fresh equity or debt funding in the near term.

Order book

The transcript does not explicitly mention specific figures or details about the current or expected order book or pending orders. However, the following points provide related insights: - Customers have deferred orders in response to the 50% US tariff imposed in August 2025, impacting export volumes temporarily. - Demand is subdued due to changes in GST, with customers reassessing blend compositions and delaying purchases, especially in Mint and Menthol categories. - Pent-up demand is expected to return around Q4 FY '26 as customers adjust formulations and external issues (tariffs, GST) stabilize. - Management is optimistic about ramping up production and revenues from new customers starting Q4 FY '26 into FY '27. - There are advanced discussions with multiple new customers, including in the confectionary segment for Cooling Agents. - Overall, the management expects normalization and growth in order inflows in the coming quarters as external headwinds ease. No precise order book numbers are disclosed in the call.

See what Gem Aromatics Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

GEM Aromatics is investing in a multi-purpose plant, with Phase-II (primarily for Phenol derivatives such as MEHQ and Guaiacol) becoming operational by November 30, 2025, with production starting around January/February 2026.
The company is adding a capacity of around 10,829 MTPA focusing largely on Phenol derivatives.
The Cooling Agent production is set to commence by November 30, 2025, with reasonable utilization expected from December 2025 and normalization in FY '27.
The company is fast-tracking the launch of value-added specialty aroma chemical products, originally planned for FY '27 and FY '28, to mitigate current market headwinds.
GEM Aromatics aims for consolidated EBITDA of Rs. 1,050-Rs. 1,100 crores with margins of 16%-18% by FY '28 driven by these expansions.
IPO proceeds have been used for partial repayment of borrowings to strengthen the balance sheet and support growth investments.

Track Gem Aromatics Ltd — get its next earnings analysis in your feed

How does Gem Aromatics Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisGem Aromatics Ltd

Rev 3Mar 3

See where Gem Aromatics Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Gem Aromatics Ltd rank in Chemicals & Petrochemicals?

Compare Gem Aromatics Ltd against every Chemicals & Petrochemicals company (Q2 FY26) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Gem Aromatics Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Alufluoride Ltd (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Gem Aromatics Ltd Q2 FY26 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Gem Aromatics Ltd rank in Chemicals & Petrochemicals?

Continue your research

What Gem Aromatics Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season